News
Tourmaline touts cardiovascular potential of former Pfizer antibody after phase 2 kidney disease win
Pacibekitug, an antibody targeting interleukin-6, hit the primary endpoint in the phase 2 Tranquility trial by sharply ...
With over 15 years of experience in public policy, Ranjan brings deep expertise from his leadership roles at Dream11, WhatsApp, JUUL Labs, and Uber.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback